2q37 Microdeletion Syndrome

1. Disease Information

1.1 Definition / overview

2q37 microdeletion/deletion syndrome is a rare subtelomeric deletion disorder caused by heterozygous deletion of the distal long arm of chromosome 2 (2q37), with variable deletion size and gene content. Clinically, it is characterized by developmental delay/intellectual disability (DD/ID), behavioral abnormalities (including autism spectrum disorder), characteristic facial dysmorphism, and skeletal anomalies—particularly brachydactyly type E/brachymetaphalangy. (gavril2023genotype–phenotypecorrelationsin pages 1-2, williams2010haploinsufficiencyofhdac4 pages 1-2)

A major current understanding (supported by deletion mapping and intragenic variants) is that haploinsufficiency of HDAC4 is the principal driver of the “core” brachydactyly–neurodevelopmental phenotype, with additional genes in larger deletions contributing to variable expressivity. (williams2010haploinsufficiencyofhdac4 pages 1-2, williams2010haploinsufficiencyofhdac4 pages 3-4)

1.2 Key identifiers

• OMIM/MIM disease ID: 600430 (brachydactyly-mental retardation syndrome; BDMR) (villavicenciolorini2013phenotypicvariantof pages 1-2, takeyari2023afamilywith pages 1-7)
• Orphanet (ORPHA): 1001 (explicitly stated for “2q37.3 deletion syndrome”) (massoniUnknownyearsíndromedadeleção pages 1-5)

1.3 Common synonyms / alternative names

• 2q37 deletion syndrome / 2q37 microdeletion syndrome / 2q37-deletion syndrome (gavril2023genotype–phenotypecorrelationsin pages 1-2, falk2007chromosome2q37deletion pages 1-2)
• 2q37.3 deletion syndrome / monosomy 2q37.3 (falk2007chromosome2q37deletion pages 1-2, gavril2023genotype–phenotypecorrelationsin pages 14-14)
• Brachydactyly-mental retardation syndrome (BDMR) (villavicenciolorini2013phenotypicvariantof pages 1-2, takeyari2023afamilywith pages 1-7)
• “Albright hereditary osteodystrophy-like syndrome/phenotype” (AHO-like) (villavicenciolorini2013phenotypicvariantof pages 1-2, falk2007chromosome2q37deletion pages 1-2)

1.4 Evidence source types

• Aggregated disease-level resources/reviews and cohorts: 2007 clinical review; 2010 causal gene mapping paper; 2013 cohort update; 2023 cohort/review. (falk2007chromosome2q37deletion pages 1-2, williams2010haploinsufficiencyofhdac4 pages 1-2, leroy2013the2q37deletionsyndrome pages 5-7, gavril2023genotype–phenotypecorrelationsin pages 1-2)
• Individual/family case reports: familial HDAC4 missense variant (2023); three-generation familial interstitial deletion (2013); oral management report (2026). (takeyari2023afamilywith pages 1-7, villavicenciolorini2013phenotypicvariantof pages 3-5, homma2026longtermoralmanagement pages 7-8)
• Observational research registry: Simons Searchlight (NCT01238250). (NCT01238250 chunk 1)

2. Etiology

2.1 Disease causal factors

Primary cause: germline heterozygous deletions affecting 2q37 (terminal or interstitial), including the HDAC4 locus; complex unbalanced rearrangements can also produce the effective 2q37 monosomy. (gavril2023genotype–phenotypecorrelationsin pages 1-2, gavril2023genotype–phenotypecorrelationsin pages 4-7)

Causal gene-level mechanism: HDAC4 haploinsufficiency. Williams et al. delineated the critical region to HDAC4 and identified de novo intragenic HDAC4 mutations in individuals with a BDMR phenotype but without a 2q37 deletion, supporting causality. (williams2010haploinsufficiencyofhdac4 pages 1-2, williams2010haploinsufficiencyofhdac4 pages 3-4)

2.2 Risk factors

Because this is a genomic deletion/variant syndrome, “risk factors” are primarily genetic: - De novo CNVs: most cases are reported as de novo, with a minority inherited. (villavicenciolorini2013phenotypicvariantof pages 3-5) - Parental balanced rearrangements can increase recurrence risk in a family (unbalanced translocations leading to 2q37 monosomy). (morris2012dosedependentexpression pages 1-2, falk2007chromosome2q37deletion pages 1-2)

Environmental risk factors are not established in the retrieved evidence (not applicable as primary etiology).

2.3 Protective factors / gene–environment interactions

No validated protective factors or gene–environment interactions specific to 2q37 deletion syndrome were identified in the retrieved evidence.

3. Phenotypes (with HPO suggestions)

A structured phenotype-to-HPO mapping with frequencies is provided below.

Table: This table maps major clinical findings reported for 2q37 deletion syndrome/BDMR to suggested HPO terms and summarizes available frequencies or quantitative notes from the extracted literature. It is useful for phenotype annotation and knowledge-base curation.

Phenotype characteristics (onset, severity, course)

• Onset: typically congenital/early childhood neurodevelopmental delay and hypotonia; skeletal findings are congenital/developmental. (gavril2023genotype–phenotypecorrelationsin pages 1-2, falk2007chromosome2q37deletion pages 11-13)
• Severity/expressivity: variable; deletion size does not reliably correlate with severity in a 2023 cohort (“the size of the deletion cannot be correlated with the severity of the abnormal phenotype”). (gavril2023genotype–phenotypecorrelationsin pages 8-10)
• Progression: developmental disability is generally lifelong; obesity may become more prominent with age in some patients. (morris2012dosedependentexpression pages 1-2)

Quality of life impact

The retrieved evidence supports substantial impacts through global DD/ID, behavioral dysregulation/autism traits, hypotonia, and multisystem malformations requiring surveillance and intervention, motivating multidisciplinary care pathways. (falk2007chromosome2q37deletion pages 11-13)

4. Genetic / Molecular Information

A structured summary of genetics and diagnostics is provided here.

Table: This table summarizes the key molecular etiology and diagnostic evidence for 2q37 deletion syndrome/BDMR, emphasizing HDAC4 haploinsufficiency, typical CNV findings, inheritance patterns, and current testing strategies. It also includes a recent tumor-surveillance note relevant to counseling and follow-up.

4.1 Causal genes and key molecular lesion classes

• Causal/major gene: HDAC4 (class IIa histone deacetylase). (williams2010haploinsufficiencyofhdac4 pages 1-2, wakeling2021missensesubstitutionsat pages 1-6)
• Structural variants: terminal/interstitial 2q37 deletions and complex rearrangements; 2023 cohort range 1.84–8.14 Mb with both pure deletions and deletion/duplication rearrangements. (gavril2023genotype–phenotypecorrelationsin pages 4-7)
• Intragenic HDAC4 variants:
• De novo intragenic disruptions (intragenic deletion affecting splicing; frameshift insertion) in the AJHG 2010 study support direct gene causality. (williams2010haploinsufficiencyofhdac4 pages 1-2)
• A familial likely pathogenic missense variant HDAC4 NM_001378414.1:c.2204G>A (p.Arg735Gln) was identified by WES in a family with BDMR features. (takeyari2023afamilywith pages 1-7)

4.2 Inheritance

At the “molecular” level, a single heterozygous pathogenic deletion or HDAC4 LoF is sufficient (autosomal dominant mechanism), but most cases are de novo; familial transmission occurs (including a three-generation interstitial deletion including HDAC4). (villavicenciolorini2013phenotypicvariantof pages 3-5, morris2012dosedependentexpression pages 1-2)

4.3 Epigenetic information

The syndrome is often discussed within “chromatinopathy” frameworks because HDAC4 is an epigenetic regulator; however, syndrome-specific DNA methylation signatures were not provided in the retrieved evidence.

5. Mechanism / Pathophysiology

5.1 Key molecular pathways and causal chain (current understanding)

Upstream trigger: heterozygous deletion/disruption of 2q37 including HDAC4, reducing HDAC4 dosage or altering protein function/localization. (williams2010haploinsufficiencyofhdac4 pages 1-2, williams2010haploinsufficiencyofhdac4 pages 3-4)

Core downstream mechanisms (evidence-supported): 1) Skeletal development (chondrocyte maturation/ossification): HDAC4 acts as a transcriptional corepressor and (with HDAC9/HDAC3) inhibits transcription factors including RUNX2 and MEF2C, which are critical for chondrocyte hypertrophy and skeletal development. Hdac4−/− mice show premature ossification and severe bone malformations, supporting a direct mechanistic link to brachydactyly type E. (williams2010haploinsufficiencyofhdac4 pages 7-8, williams2010haploinsufficiencyofhdac4 pages 1-2)

2) Neurodevelopment (HDAC4 nucleocytoplasmic shuttling; MEF2 dependence): HDAC4 shuttles between nucleus and cytoplasm in a phosphorylation/14-3-3–dependent manner; MEF2 binding promotes nuclear entry. In Drosophila neuronal morphogenesis models, forced nuclear or cytoplasmic sequestration disrupts axon morphogenesis in mushroom body neurons, and effects depend on the MEF2-binding region. This supports the plausibility that altered HDAC4 dosage/localization perturbs neuronal development and synaptic programs contributing to DD/ID and behavioral phenotypes. (tan2024decipheringtheroles pages 1-2, tan2024decipheringtheroles pages 2-4)

3) Nuclear architecture and long-range gene regulation: In patient-derived mesenchymal stem cells (MSCs) and derived skeletal lineages, a 2q37 deletion including HDAC4 altered inter-chromosomal arrangements and interactions between chromosome 2 and chromosomes 12/17; Hi-C and DNA-FISH support a “direct link between a structural chromosomal aberration and altered interphase architecture.” This provides an additional pathophysiologic layer—beyond “single-gene dosage”—where chromosome territory organization and nuclear higher-order contacts may affect gene expression relevant to chondrogenesis (e.g., loci near PTHLH/NOG mentioned in the mechanistic synthesis). (maass2018reorganizationofinter‐chromosomal pages 1-2, maass2018reorganizationofinter‐chromosomal pages 2-3)

5.2 Cell types (CL terms) and anatomical contexts

• Mesenchymal stem cells (CL:0000134) and derived skeletal lineages (chondrocytes/osteocytes) studied in Maass et al. as a mechanistic system. (maass2018reorganizationofinter‐chromosomal pages 1-2)
• Neurons (CL:0000540), including Drosophila mushroom body circuits as a neurodevelopmental model. (tan2024decipheringtheroles pages 1-2)
• Chondrocytes (CL:0000138) and skeletal development contexts inferred from Hdac4 mouse data. (williams2010haploinsufficiencyofhdac4 pages 7-8)

5.3 GO biological process term suggestions (non-exhaustive)

Based on the mechanistic evidence above: - Chondrocyte hypertrophy / endochondral ossification; regulation of ossification; skeletal system development (supported by Hdac4-null premature ossification phenotype and RUNX2/MEF2C repression). (williams2010haploinsufficiencyofhdac4 pages 7-8) - Regulation of transcription by RNA polymerase II; chromatin organization; histone deacetylation–related regulation (HDAC4 core function). (williams2010haploinsufficiencyofhdac4 pages 1-2) - Neuron projection development / axon morphogenesis; regulation of synaptic plasticity programs (supported by Drosophila morphogenesis dependencies on HDAC4 localization and MEF2 interaction). (tan2024decipheringtheroles pages 1-2)

5.4 Distinguishing LoF/haploinsufficiency vs gain-of-function (expert analysis)

A key nuance in current expert interpretation is that not all HDAC4 variants phenocopy classical BDMR. Missense variants in the conserved 14-3-3 binding motif can reduce 14-3-3 binding and increase nuclear HDAC4 activity, producing a distinct intellectual disability syndrome that differs mechanistically from haploinsufficiency-driven BDMR. This distinction is important for variant interpretation in clinical genomics. (wakeling2021missensesubstitutionsat pages 1-6, wakeling2021missensesubstitutionsat pages 9-12)

6. Diagnostics

6.1 Genetic testing approach (real-world implementation)

• Chromosomal microarray (CMA/array-CGH) is described as the practical “gold standard” for defining 2q37 deletions (size and gene content). (gavril2023genotype–phenotypecorrelationsin pages 11-12)
• A cost-effective workflow used in a 2023 cohort: subtelomeric MLPA screening followed by CGH-array to confirm size/location and detect additional CNVs. (gavril2023genotype–phenotypecorrelationsin pages 4-7, gavril2023genotype–phenotypecorrelationsin pages 11-12)
• Karyotype/FISH can clarify rearrangements and confirm deletions in familial or complex cases. (villavicenciolorini2013phenotypicvariantof pages 3-5, falk2007chromosome2q37deletion pages 11-13)
• WES is useful when a BDMR phenotype is present but no deletion is detected, enabling identification of intragenic HDAC4 variants (e.g., p.Arg735Gln). (takeyari2023afamilywith pages 1-7)

6.2 Differential diagnosis (syndromic considerations)

Retrieved evidence emphasizes overlap with AHO-like phenotypes and other neurodevelopmental/chromatin disorders, and that brachydactyly type E has a broad differential. (villavicenciolorini2013phenotypicvariantof pages 1-2, leroy2013the2q37deletionsyndrome pages 5-7)

7. Inheritance and Population

7.1 Epidemiology (statistics from studies)

Epidemiology estimates depend strongly on ascertainment (learning disability referral vs population screening): - Subtelomeric deletions associated with developmental delays account for ~2.5% of the aetiology of learning disabilities (in the context of subtelomeric testing paradigms). (leroy2013the2q37deletionsyndrome pages 5-7) - In a large telomere-screening study of 11,688 specimens, seven had a 2q37 deletion (reported as 0.06% overall; 4% of all terminal deletions detected in that study). (falk2007chromosome2q37deletion pages 1-2) - In a selected cohort of 150 syndromic, previously undiagnosed individuals with intellectual disability, 15 (10%) had cryptic subtelomeric rearrangements; 3 had breakpoints at 2q37. (falk2007chromosome2q37deletion pages 1-2) - Case-count statements in older literature are heterogeneous and may include diverse 2q subtelomeric findings; for example, Leroy et al. cite thousands of identified cases in telomeric FISH series/literature, but denominators and pathogenicity classification can be unclear. (leroy2013the2q37deletionsyndrome pages 1-2)

7.2 Inheritance, penetrance, expressivity

• A three-generation familial interstitial deletion including HDAC4 demonstrates familial transmission with variable expressivity. (villavicenciolorini2013phenotypicvariantof pages 3-5)
• Dose-dependent HDAC4 expression differences were reported in an inherited translocation context, supporting variable expressivity linked to effective dosage. (morris2012dosedependentexpression pages 1-2)

8. Treatment / Management / Prevention

8.1 Disease-specific pharmacotherapy

No disease-specific pharmacologic therapy was identified in the retrieved evidence.

8.2 Supportive care and surveillance (current practice patterns)

A detailed management framework is provided in the 2007 clinical review, emphasizing multisystem baseline evaluation and longitudinal surveillance: - At diagnosis: echocardiogram and renal ultrasound; confirm cytogenetic diagnosis with high-resolution methods (FISH/CGH). (falk2007chromosome2q37deletion pages 11-13) - Early/ongoing: address feeding issues/failure to thrive, hypotonia, GERD/hiatal hernia; consider pyloric stenosis if projectile vomiting; baseline ophthalmology and periodic hearing tests; developmental/educational interventions; evaluation and intervention for behavioral/autism concerns; monitor growth/obesity. (falk2007chromosome2q37deletion pages 11-13) - Renal/tumor: Falk et al. propose Wilms tumor surveillance for children with breakpoints at or proximal to 2q37.1 (particularly in first 8 years), and repeat renal sonography at later ages for more distal deletions to screen for renal cysts. (falk2007chromosome2q37deletion pages 11-13)

8.3 Tumor surveillance (updated expert guidance; 2024)

A 2024 AACR Pediatric Cancer Working Group update includes an entry for 2p24 duplication/2q37 deletion with undefined Wilms tumor risk and recommends shared decision making rather than routine surveillance based on a defined risk estimate; hepatoblastoma risk is not indicated for this entry. (kalish2024updateonsurveillance pages 19-20)

8.4 Dental/oral management (real-world implementation)

Long-term dental management in a 2q37 deletion patient emphasized behavior shaping, caregiver engagement, and frequent preventive follow-up (monthly acclimation visits transitioning to 3–4 month recalls); in the presence of congenital heart disease, prophylactic antibiotics before invasive dental procedures may be needed to prevent infective endocarditis. (homma2026longtermoralmanagement pages 7-8)

8.5 Prevention (genetic counseling; secondary prevention)

Primary prevention is not applicable for de novo genomic disorders; key preventive strategies are: - Genetic counseling on recurrence risk (low in de novo cases; higher if a parent carries a balanced rearrangement or the deletion is inherited). (villavicenciolorini2013phenotypicvariantof pages 3-5, falk2007chromosome2q37deletion pages 1-2) - Prenatal diagnosis and family cascade testing when a pathogenic familial rearrangement/deletion is known (implied by familial reports and diagnostic approaches). (villavicenciolorini2013phenotypicvariantof pages 3-5)

8.6 MAXO term suggestions (non-exhaustive)

From evidence-supported management components: - Chromosomal microarray analysis / copy number testing; FISH confirmation; WES (gavril2023genotype–phenotypecorrelationsin pages 4-7, takeyari2023afamilywith pages 1-7, falk2007chromosome2q37deletion pages 11-13) - Echocardiography; renal ultrasonography; Wilms tumor surveillance ultrasound (falk2007chromosome2q37deletion pages 11-13) - Early intervention services; special education; behavioral therapy (falk2007chromosome2q37deletion pages 11-13) - Preventive dental care; orthodontic treatment for malocclusion (homma2026longtermoralmanagement pages 7-8)

9. Other Species / Natural Disease

No naturally occurring veterinary analogue was identified in the retrieved evidence.

10. Model Organisms

10.1 Mouse

Hdac4-null mice show premature ossification and severe bone malformations, supporting skeletal mechanism relevance to brachydactyly type E. (williams2010haploinsufficiencyofhdac4 pages 1-2, williams2010haploinsufficiencyofhdac4 pages 7-8)

10.2 Drosophila

Drosophila models dissected the roles of HDAC4 localization (nuclear/cytoplasmic sequestration), MEF2 binding region, and other motifs in neuronal morphogenesis, demonstrating axon morphogenesis defects and neuronal-subtype-specific dependencies. (tan2024decipheringtheroles pages 1-2, tan2024decipheringtheroles pages 2-4)

10.3 Patient-derived cells

Human mesenchymal stem cells and derived lineages were used to show altered inter-chromosomal interactions in a three-generation family with a 2q37 deletion including HDAC4. (maass2018reorganizationofinter‐chromosomal pages 1-2)

11. Recent Developments (2023–2024 prioritized)

1) Clinical spectrum expansion and genotype–phenotype updates (2023): A 2023 cohort (n=9) confirmed high rates of facial dysmorphism (9/9), DD/ID (8/9), skeletal anomalies (8/9), and reported underrecognized findings such as translucent skin/telangiectasias (6/9) and an upper-thorax fat hump (5/9). (gavril2023genotype–phenotypecorrelationsin pages 1-2, gavril2023genotype–phenotypecorrelationsin pages 11-12)

2) HDAC4 sequence-level etiology beyond deletions (2023): A family with BDMR carried a likely pathogenic HDAC4 missense variant (p.Arg735Gln) found by WES, expanding clinically actionable variant interpretation beyond CNVs. (takeyari2023afamilywith pages 1-7)

3) Mechanistic neurodevelopment advances relevant to HDAC4 (2024): Drosophila studies in 2024 dissected how HDAC4 subcellular localization and MEF2 interaction control neuronal morphogenesis, reinforcing HDAC4 as a neurodevelopmental regulator and highlighting cell-type-specific requirements for different HDAC4 domains. (tan2024decipheringtheroles pages 1-2)

4) Updated tumor surveillance guidance context (2024): AACR surveillance updates explicitly list 2p24 duplication/2q37 deletion with “shared decision” for Wilms tumor surveillance due to undefined risk, reflecting contemporary practice of risk-threshold-driven screening recommendations. (kalish2024updateonsurveillance pages 19-20)

12. Current Applications and Real-World Implementations

• Diagnostics in clinical genetics: CMA/array-CGH as first-tier testing for suspected syndromic DD/ID and dysmorphism; MLPA can be used for subtelomeric screening followed by array confirmation. (gavril2023genotype–phenotypecorrelationsin pages 11-12, gavril2023genotype–phenotypecorrelationsin pages 4-7)
• Family-based longitudinal research participation: Simons Searchlight (NCT01238250) explicitly includes “2Q37 Deletion Syndrome” and “2q37.3 Deletion,” enabling remote enrollment and longitudinal phenotype capture, with de-identified data sharing for qualified researchers. (NCT01238250 chunk 1, NCT01238250 chunk 2)
• Clinical care pathways: multidisciplinary baseline evaluation (cardiac/renal imaging, hearing/vision assessment), neurodevelopmental supports, and targeted management of malformations and behavioral issues as described in clinical guidance. (falk2007chromosome2q37deletion pages 11-13)

13. Visual evidence (critical region mapping)

Williams et al. 2010 includes a deletion-mapping figure delineating the BDMR critical region to HDAC4, supporting gene causality through overlapping deletions. (williams2010haploinsufficiencyofhdac4 media ef4f19fc, williams2010haploinsufficiencyofhdac4 media 88beca26)

Key limitations of this evidence set (transparency)

• ICD-10/ICD-11, MeSH, and MONDO identifiers were not explicitly available in retrieved texts; they are not asserted.
• Some frequency values in the phenotype table rely on secondary reporting of a 103-case review within a 2023 family report; primary extraction of that 103-case cohort paper was not available in this run.
• Tumor risk estimates specific to isolated 2q37 deletion syndrome remain uncertain in retrieved 2024 guideline tables (listed as “undefined”), and older surveillance suggestions differ by breakpoint assumptions and historical evidence. (kalish2024updateonsurveillance pages 19-20, falk2007chromosome2q37deletion pages 11-13)

References

1. (gavril2023genotype–phenotypecorrelationsin pages 1-2): Eva-Cristiana Gavril, Irina Nucă, Monica-Cristina Pânzaru, Anca Viorica Ivanov, Cosmin-Teodor Mihai, Lucian-Mihai Antoci, Cristian-Gabriel Ciobanu, Cristina Rusu, and Roxana Popescu. Genotype–phenotype correlations in 2q37-deletion syndrome: an update of the clinical spectrum and literature review. Genes, 14:465, Feb 2023. URL: https://doi.org/10.3390/genes14020465, doi:10.3390/genes14020465. This article has 16 citations.

2. (williams2010haploinsufficiencyofhdac4 pages 1-2): Stephen R. Williams, Micheala A. Aldred, Vazken M. Der Kaloustian, Fahed Halal, Gordon Gowans, D. Ross McLeod, Sara Zondag, Helga V. Toriello, R. Ellen Magenis, and Sarah H. Elsea. Haploinsufficiency of hdac4 causes brachydactyly mental retardation syndrome, with brachydactyly type e, developmental delays, and behavioral problems. American journal of human genetics, 87 2:219-28, Aug 2010. URL: https://doi.org/10.1016/j.ajhg.2010.07.011, doi:10.1016/j.ajhg.2010.07.011. This article has 363 citations and is from a highest quality peer-reviewed journal.

3. (williams2010haploinsufficiencyofhdac4 pages 3-4): Stephen R. Williams, Micheala A. Aldred, Vazken M. Der Kaloustian, Fahed Halal, Gordon Gowans, D. Ross McLeod, Sara Zondag, Helga V. Toriello, R. Ellen Magenis, and Sarah H. Elsea. Haploinsufficiency of hdac4 causes brachydactyly mental retardation syndrome, with brachydactyly type e, developmental delays, and behavioral problems. American journal of human genetics, 87 2:219-28, Aug 2010. URL: https://doi.org/10.1016/j.ajhg.2010.07.011, doi:10.1016/j.ajhg.2010.07.011. This article has 363 citations and is from a highest quality peer-reviewed journal.

4. (villavicenciolorini2013phenotypicvariantof pages 1-2): Pablo Villavicencio-Lorini, Eva Klopocki, Marc Trimborn, Randi Koll, Stefan Mundlos, and Denise Horn. Phenotypic variant of brachydactyly-mental retardation syndrome in a family with an inherited interstitial 2q37.3 microdeletion including hdac4. European Journal of Human Genetics, 21:743-748, Nov 2013. URL: https://doi.org/10.1038/ejhg.2012.240, doi:10.1038/ejhg.2012.240. This article has 70 citations and is from a domain leading peer-reviewed journal.

5. (takeyari2023afamilywith pages 1-7): Shinji Takeyari, Kenichi Yamamoto, Makoto Fujiwara, Yasuhisa Ohata, Taichi Kitaoka, Takuo Kubota, Miho Nagata, Yasuki Ishihara, Yohei Miyashita, Yoshihiro Asano, and Keiichi Ozono. A family with brachydactyly mental retardation syndrome with a missense variant in hdac4. Clinical Pediatric Endocrinology, 32:105-109, Feb 2023. URL: https://doi.org/10.1297/cpe.2022-0076, doi:10.1297/cpe.2022-0076. This article has 0 citations and is from a peer-reviewed journal.

6. (massoniUnknownyearsíndromedadeleção pages 1-5): VV Massoni. Síndrome da deleção 2q37. 3–a primeira descrição de achados orais, relato de caso. Unknown journal, Unknown year.

7. (falk2007chromosome2q37deletion pages 1-2): Rena E. Falk and Kari A. Casas. Chromosome 2q37 deletion: clinical and molecular aspects. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 145C:357-371, Nov 2007. URL: https://doi.org/10.1002/ajmg.c.30153, doi:10.1002/ajmg.c.30153. This article has 134 citations.

8. (gavril2023genotype–phenotypecorrelationsin pages 14-14): Eva-Cristiana Gavril, Irina Nucă, Monica-Cristina Pânzaru, Anca Viorica Ivanov, Cosmin-Teodor Mihai, Lucian-Mihai Antoci, Cristian-Gabriel Ciobanu, Cristina Rusu, and Roxana Popescu. Genotype–phenotype correlations in 2q37-deletion syndrome: an update of the clinical spectrum and literature review. Genes, 14:465, Feb 2023. URL: https://doi.org/10.3390/genes14020465, doi:10.3390/genes14020465. This article has 16 citations.

9. (leroy2013the2q37deletionsyndrome pages 5-7): Camille Leroy, Emilie Landais, Sylvain Briault, Albert David, Olivier Tassy, Nicolas Gruchy, Bruno Delobel, Marie-José Grégoire, Bruno Leheup, Laurence Taine, Didier Lacombe, Marie-Ange Delrue, Annick Toutain, Agathe Paubel, Francine Mugneret, Christel Thauvin-Robinet, Stéphanie Arpin, Cedric Le Caignec, Philippe Jonveaux, Mylène Beri, Nathalie Leporrier, Jacques Motte, Caroline Fiquet, Olivier Brichet, Monique Mozelle-Nivoix, Pascal Sabouraud, Nathalie Golovkine, Nathalie Bednarek, Dominique Gaillard, and Martine Doco-Fenzy. The 2q37-deletion syndrome: an update of the clinical spectrum including overweight, brachydactyly and behavioural features in 14 new patients. European Journal of Human Genetics, 21:602-612, Oct 2013. URL: https://doi.org/10.1038/ejhg.2012.230, doi:10.1038/ejhg.2012.230. This article has 113 citations and is from a domain leading peer-reviewed journal.

10. (villavicenciolorini2013phenotypicvariantof pages 3-5): Pablo Villavicencio-Lorini, Eva Klopocki, Marc Trimborn, Randi Koll, Stefan Mundlos, and Denise Horn. Phenotypic variant of brachydactyly-mental retardation syndrome in a family with an inherited interstitial 2q37.3 microdeletion including hdac4. European Journal of Human Genetics, 21:743-748, Nov 2013. URL: https://doi.org/10.1038/ejhg.2012.240, doi:10.1038/ejhg.2012.240. This article has 70 citations and is from a domain leading peer-reviewed journal.

11. (homma2026longtermoralmanagement pages 7-8): Hiromi Homma, Atsuo Sakurai, Dai Ariizumi, Yasushi Nishii, and Seikou Shintani. Long-term oral management for 2q37 deletion syndrome patient. The Bulletin of Tokyo Dental College, Feb 2026. URL: https://doi.org/10.2209/tdcpublication.2025-0022, doi:10.2209/tdcpublication.2025-0022. This article has 0 citations.

12. (NCT01238250 chunk 1): Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight. Simons Searchlight. 2010. ClinicalTrials.gov Identifier: NCT01238250

13. (gavril2023genotype–phenotypecorrelationsin pages 4-7): Eva-Cristiana Gavril, Irina Nucă, Monica-Cristina Pânzaru, Anca Viorica Ivanov, Cosmin-Teodor Mihai, Lucian-Mihai Antoci, Cristian-Gabriel Ciobanu, Cristina Rusu, and Roxana Popescu. Genotype–phenotype correlations in 2q37-deletion syndrome: an update of the clinical spectrum and literature review. Genes, 14:465, Feb 2023. URL: https://doi.org/10.3390/genes14020465, doi:10.3390/genes14020465. This article has 16 citations.

14. (morris2012dosedependentexpression pages 1-2): Benjamin Morris, Cécile Etoubleau, Sylvie Bourthoumieu, Sandrine Reynaud‐Perrine, Cécile Laroche, Aziza Lebbar, Catherine Yardin, and Sarah H. Elsea. Dose dependent expression of hdac4 causes variable expressivity in a novel inherited case of brachydactyly mental retardation syndrome. American Journal of Medical Genetics Part A, 158A:2015-2020, Aug 2012. URL: https://doi.org/10.1002/ajmg.a.35463, doi:10.1002/ajmg.a.35463. This article has 50 citations.

15. (gavril2023genotype–phenotypecorrelationsin pages 10-11): Eva-Cristiana Gavril, Irina Nucă, Monica-Cristina Pânzaru, Anca Viorica Ivanov, Cosmin-Teodor Mihai, Lucian-Mihai Antoci, Cristian-Gabriel Ciobanu, Cristina Rusu, and Roxana Popescu. Genotype–phenotype correlations in 2q37-deletion syndrome: an update of the clinical spectrum and literature review. Genes, 14:465, Feb 2023. URL: https://doi.org/10.3390/genes14020465, doi:10.3390/genes14020465. This article has 16 citations.

16. (takeyari2023afamilywith pages 7-11): Shinji Takeyari, Kenichi Yamamoto, Makoto Fujiwara, Yasuhisa Ohata, Taichi Kitaoka, Takuo Kubota, Miho Nagata, Yasuki Ishihara, Yohei Miyashita, Yoshihiro Asano, and Keiichi Ozono. A family with brachydactyly mental retardation syndrome with a missense variant in hdac4. Clinical Pediatric Endocrinology, 32:105-109, Feb 2023. URL: https://doi.org/10.1297/cpe.2022-0076, doi:10.1297/cpe.2022-0076. This article has 0 citations and is from a peer-reviewed journal.

17. (gavril2023genotype–phenotypecorrelationsin pages 11-12): Eva-Cristiana Gavril, Irina Nucă, Monica-Cristina Pânzaru, Anca Viorica Ivanov, Cosmin-Teodor Mihai, Lucian-Mihai Antoci, Cristian-Gabriel Ciobanu, Cristina Rusu, and Roxana Popescu. Genotype–phenotype correlations in 2q37-deletion syndrome: an update of the clinical spectrum and literature review. Genes, 14:465, Feb 2023. URL: https://doi.org/10.3390/genes14020465, doi:10.3390/genes14020465. This article has 16 citations.

18. (gavril2023genotype–phenotypecorrelationsin pages 8-10): Eva-Cristiana Gavril, Irina Nucă, Monica-Cristina Pânzaru, Anca Viorica Ivanov, Cosmin-Teodor Mihai, Lucian-Mihai Antoci, Cristian-Gabriel Ciobanu, Cristina Rusu, and Roxana Popescu. Genotype–phenotype correlations in 2q37-deletion syndrome: an update of the clinical spectrum and literature review. Genes, 14:465, Feb 2023. URL: https://doi.org/10.3390/genes14020465, doi:10.3390/genes14020465. This article has 16 citations.

19. (falk2007chromosome2q37deletion pages 11-13): Rena E. Falk and Kari A. Casas. Chromosome 2q37 deletion: clinical and molecular aspects. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 145C:357-371, Nov 2007. URL: https://doi.org/10.1002/ajmg.c.30153, doi:10.1002/ajmg.c.30153. This article has 134 citations.

20. (wakeling2021missensesubstitutionsat pages 1-6): Emma Wakeling, Meriel McEntagart, Michael Bruccoleri, Charles Shaw-Smith, Karen L. Stals, Matthew Wakeling, Angela Barnicoat, Clare Beesley, Andrea K. Hanson-Kahn, Mary Kukolich, David A. Stevenson, Philippe M. Campeau, Sian Ellard, Sarah H. Elsea, Xiang-Jiao Yang, and Richard C. Caswell. Missense substitutions at a conserved 14-3-3 binding site in hdac4 cause a novel intellectual disability syndrome. Human Genetics and Genomics Advances, 2:100015, Jan 2021. URL: https://doi.org/10.1016/j.xhgg.2020.100015, doi:10.1016/j.xhgg.2020.100015. This article has 24 citations and is from a peer-reviewed journal.

21. (wakeling2021missensesubstitutionsat pages 6-9): Emma Wakeling, Meriel McEntagart, Michael Bruccoleri, Charles Shaw-Smith, Karen L. Stals, Matthew Wakeling, Angela Barnicoat, Clare Beesley, Andrea K. Hanson-Kahn, Mary Kukolich, David A. Stevenson, Philippe M. Campeau, Sian Ellard, Sarah H. Elsea, Xiang-Jiao Yang, and Richard C. Caswell. Missense substitutions at a conserved 14-3-3 binding site in hdac4 cause a novel intellectual disability syndrome. Human Genetics and Genomics Advances, 2:100015, Jan 2021. URL: https://doi.org/10.1016/j.xhgg.2020.100015, doi:10.1016/j.xhgg.2020.100015. This article has 24 citations and is from a peer-reviewed journal.

22. (williams2010haploinsufficiencyofhdac4 media ef4f19fc): Stephen R. Williams, Micheala A. Aldred, Vazken M. Der Kaloustian, Fahed Halal, Gordon Gowans, D. Ross McLeod, Sara Zondag, Helga V. Toriello, R. Ellen Magenis, and Sarah H. Elsea. Haploinsufficiency of hdac4 causes brachydactyly mental retardation syndrome, with brachydactyly type e, developmental delays, and behavioral problems. American journal of human genetics, 87 2:219-28, Aug 2010. URL: https://doi.org/10.1016/j.ajhg.2010.07.011, doi:10.1016/j.ajhg.2010.07.011. This article has 363 citations and is from a highest quality peer-reviewed journal.

23. (kalish2024updateonsurveillance pages 19-20): Jennifer M. Kalish, Kerri D. Becktell, Gaëlle Bougeard, Garrett M. Brodeur, Lisa R. Diller, Andrea S. Doria, Jordan R. Hansford, Steven D. Klein, Wendy K. Kohlmann, Christian P. Kratz, Suzanne P. MacFarland, Kristian W. Pajtler, Surya P. Rednam, Jaclyn Schienda, Lisa J. States, Anita Villani, Rosanna Weksberg, Kristin Zelley, Gail E. Tomlinson, and Jack J. Brzezinski. Update on surveillance for wilms tumor and hepatoblastoma in beckwith-wiedemann syndrome and other predisposition syndromes. Clinical cancer research : an official journal of the American Association for Cancer Research, 30:5260-5269, Sep 2024. URL: https://doi.org/10.1158/1078-0432.ccr-24-2100, doi:10.1158/1078-0432.ccr-24-2100. This article has 46 citations.

24. (williams2010haploinsufficiencyofhdac4 pages 7-8): Stephen R. Williams, Micheala A. Aldred, Vazken M. Der Kaloustian, Fahed Halal, Gordon Gowans, D. Ross McLeod, Sara Zondag, Helga V. Toriello, R. Ellen Magenis, and Sarah H. Elsea. Haploinsufficiency of hdac4 causes brachydactyly mental retardation syndrome, with brachydactyly type e, developmental delays, and behavioral problems. American journal of human genetics, 87 2:219-28, Aug 2010. URL: https://doi.org/10.1016/j.ajhg.2010.07.011, doi:10.1016/j.ajhg.2010.07.011. This article has 363 citations and is from a highest quality peer-reviewed journal.

25. (tan2024decipheringtheroles pages 1-2): Wei Jun Tan, Hannah R. Hawley, Sarah J. Wilson, and Helen L. Fitzsimons. Deciphering the roles of subcellular distribution and interactions involving the mef2 binding region, the ankyrin repeat binding motif and the catalytic site of hdac4 in drosophila neuronal morphogenesis. BMC Biology, Jan 2024. URL: https://doi.org/10.1186/s12915-023-01800-1, doi:10.1186/s12915-023-01800-1. This article has 4 citations and is from a domain leading peer-reviewed journal.

26. (tan2024decipheringtheroles pages 2-4): Wei Jun Tan, Hannah R. Hawley, Sarah J. Wilson, and Helen L. Fitzsimons. Deciphering the roles of subcellular distribution and interactions involving the mef2 binding region, the ankyrin repeat binding motif and the catalytic site of hdac4 in drosophila neuronal morphogenesis. BMC Biology, Jan 2024. URL: https://doi.org/10.1186/s12915-023-01800-1, doi:10.1186/s12915-023-01800-1. This article has 4 citations and is from a domain leading peer-reviewed journal.

27. (maass2018reorganizationofinter‐chromosomal pages 1-2): Philipp G Maass, Anja Weise, Katharina Rittscher, Julia Lichtenwald, A Rasim Barutcu, Thomas Liehr, Atakan Aydin, Yvette Wefeld‐Neuenfeld, Laura Pölsler, Sigrid Tinschert, John L Rinn, Friedrich C Luft, and Sylvia Bähring. Reorganization of inter‐chromosomal interactions in the 2q37‐deletion syndrome. The EMBO Journal, Jun 2018. URL: https://doi.org/10.15252/embj.201696257, doi:10.15252/embj.201696257. This article has 22 citations.

28. (maass2018reorganizationofinter‐chromosomal pages 2-3): Philipp G Maass, Anja Weise, Katharina Rittscher, Julia Lichtenwald, A Rasim Barutcu, Thomas Liehr, Atakan Aydin, Yvette Wefeld‐Neuenfeld, Laura Pölsler, Sigrid Tinschert, John L Rinn, Friedrich C Luft, and Sylvia Bähring. Reorganization of inter‐chromosomal interactions in the 2q37‐deletion syndrome. The EMBO Journal, Jun 2018. URL: https://doi.org/10.15252/embj.201696257, doi:10.15252/embj.201696257. This article has 22 citations.

29. (wakeling2021missensesubstitutionsat pages 9-12): Emma Wakeling, Meriel McEntagart, Michael Bruccoleri, Charles Shaw-Smith, Karen L. Stals, Matthew Wakeling, Angela Barnicoat, Clare Beesley, Andrea K. Hanson-Kahn, Mary Kukolich, David A. Stevenson, Philippe M. Campeau, Sian Ellard, Sarah H. Elsea, Xiang-Jiao Yang, and Richard C. Caswell. Missense substitutions at a conserved 14-3-3 binding site in hdac4 cause a novel intellectual disability syndrome. Human Genetics and Genomics Advances, 2:100015, Jan 2021. URL: https://doi.org/10.1016/j.xhgg.2020.100015, doi:10.1016/j.xhgg.2020.100015. This article has 24 citations and is from a peer-reviewed journal.

30. (leroy2013the2q37deletionsyndrome pages 1-2): Camille Leroy, Emilie Landais, Sylvain Briault, Albert David, Olivier Tassy, Nicolas Gruchy, Bruno Delobel, Marie-José Grégoire, Bruno Leheup, Laurence Taine, Didier Lacombe, Marie-Ange Delrue, Annick Toutain, Agathe Paubel, Francine Mugneret, Christel Thauvin-Robinet, Stéphanie Arpin, Cedric Le Caignec, Philippe Jonveaux, Mylène Beri, Nathalie Leporrier, Jacques Motte, Caroline Fiquet, Olivier Brichet, Monique Mozelle-Nivoix, Pascal Sabouraud, Nathalie Golovkine, Nathalie Bednarek, Dominique Gaillard, and Martine Doco-Fenzy. The 2q37-deletion syndrome: an update of the clinical spectrum including overweight, brachydactyly and behavioural features in 14 new patients. European Journal of Human Genetics, 21:602-612, Oct 2013. URL: https://doi.org/10.1038/ejhg.2012.230, doi:10.1038/ejhg.2012.230. This article has 113 citations and is from a domain leading peer-reviewed journal.

31. (NCT01238250 chunk 2): Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight. Simons Searchlight. 2010. ClinicalTrials.gov Identifier: NCT01238250

32. (williams2010haploinsufficiencyofhdac4 media 88beca26): Stephen R. Williams, Micheala A. Aldred, Vazken M. Der Kaloustian, Fahed Halal, Gordon Gowans, D. Ross McLeod, Sara Zondag, Helga V. Toriello, R. Ellen Magenis, and Sarah H. Elsea. Haploinsufficiency of hdac4 causes brachydactyly mental retardation syndrome, with brachydactyly type e, developmental delays, and behavioral problems. American journal of human genetics, 87 2:219-28, Aug 2010. URL: https://doi.org/10.1016/j.ajhg.2010.07.011, doi:10.1016/j.ajhg.2010.07.011. This article has 363 citations and is from a highest quality peer-reviewed journal.

Artifacts

• Edison artifact artifact-00
• Edison artifact artifact-01